EMERGENT BIOSOLUTIONS INC. EBS Income Statement

Emergent biosolutions inc. (EBS)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Total revenues
192,500	360,400	311,800	243,200	190,600	270,800	173,600	220,200	117,800	193,836	149,434	100,772	116,858	151,681	142,914	91,241	102,964	141,208	158,378	126,112	63,633	102,303	137,954	110,325	53,884	98,107	89,102	82,436	43,100	94,606	66,592	70,379	50,311	107,948	58,762	88,141	18,533	73,986	62,138
Operating expenses:
Cost of product sales and contract development and manufacturing services
76,900	132,900	108,000	100,800	91,800	113,400	69,300	85,300	54,300	62,251	44,503	34,624	46,322	33,274	39,560	29,465	24,001	26,232	35,240	27,266	18,748	16,036	32,423	34,507	18,997	19,421	20,063	16,945	5,698	15,150	10,230	13,186	7,511	14,328	10,706	16,069	1,068	11,532	11,076
Research and development
42,700	62,800	53,400	63,900	46,100	52,000	37,000	24,700	29,100	28,514	22,659	25,751	20,476	25,726	27,188	27,893	26,093	5,364	34,179	40,941	38,702	-7,143	44,207	37,401	30,256	29,994	28,937	30,278	30,724	35,945	27,390	30,645	26,246	29,376	29,216	31,481	34,759	21,156	18,602
Selling, general and administrative
69,700	72,300	65,000	70,800	65,400	80,900	42,100	39,500	40,000	41,379	34,503	31,868	35,150	34,774	40,688	35,925	31,713	24,399	25,800	36,453	34,493	17,658	30,292	30,555	30,089	25,399	21,955	20,501	20,028	19,476	19,155	17,895	19,492	18,254	17,432	20,384	18,212	20,693	17,649
Amortization of Intangible Assets
14,800	14,800	14,700	14,700	14,500	13,300	3,900	3,900	3,900	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
204,100	282,800	241,100	250,200	217,800	259,600	152,300	153,400	127,300	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of in-process research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	9,600	0	0	0	0	-	-
Loss from operations
-11,600	77,600	70,700	-7,000	-27,200	11,200	21,300	66,800	-9,500	53,092	47,769	8,529	14,910	50,907	35,478	-2,042	21,157	85,213	63,159	21,452	-28,310	75,752	31,032	7,862	-25,458	23,293	18,147	14,712	-13,350	24,035	9,817	8,653	-12,538	45,990	1,408	20,207	-35,506	20,605	14,811
Other (expense) income:
Interest income
-	-	-	-	-	-	-	-	-	-	637	583	373	-	358	219	186	113	104	273	82	190	59	31	40	18	88	10	23	25	55	29	25	24	22	24	35	38	376
Interest expense
8,600	9,000	10,300	9,500	9,600	8,100	600	1,000	200	866	1,991	1,805	1,938	2,517	2,049	1,510	1,524	1,599	1,635	1,628	1,661	1,174	1,810	1,721	3,535	-14	0	3	11	3	0	0	3	-6	0	6	0	0	2
Other expense, net
-1,100	2,800	-1,500	1,400	-1,000	500	800	0	300	1,287	-101	-586	300	1,475	-234	24	35	31	519	-497	100	672	420	1,322	512	333	58	18	17	225	-16	907	854	-258	37	-39	-1	-1,003	6
Total other expense, net
-9,700	-6,200	-11,800	-8,100	-10,600	-7,600	200	-1,000	100	-1,172	-1,455	-1,808	-1,265	-1,805	-1,925	-1,267	-1,303	-1,455	-1,012	-1,852	-1,479	-312	-1,331	-368	-2,983	365	146	25	29	247	39	936	876	-228	59	-21	34	-965	380
Loss before provision for income taxes
-21,300	71,400	58,900	-15,100	-37,800	3,600	21,500	65,800	-9,400	51,920	46,314	6,721	13,645	49,102	33,553	-3,309	19,854	83,758	62,147	19,600	-29,789	75,440	29,701	7,494	-28,441	23,658	18,293	14,737	-13,321	24,282	9,856	9,589	-11,662	45,762	1,467	20,186	-35,472	19,640	15,191
Income tax benefit
-8,800	24,600	15,700	-5,600	-11,800	7,000	600	15,700	-4,500	17,972	12,763	2,105	3,160	16,837	13,165	-1,267	7,965	27,010	20,059	5,500	-8,269	27,799	7,869	2,465	-8,205	8,441	4,802	4,381	-4,516	9,283	4,236	4,043	-3,640	18,862	1,604	7,663	-12,299	7,696	5,757
Net income from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	32,265	20,388	-2,042	11,889	-	42,088	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	5,151	952	-8,905	-7,898	-	-5,145	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,100	-21,520	30,116	21,832	5,029	-20,236	15,217	13,491	10,356	-8,805	14,999	5,620	5,546	-8,022	26,900	-137	12,523	-23,173	11,944	9,434
Net loss attributable to noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5	0	-128	-743	-1,105	-997	-2,086	-1,193	-1,757	-1,686	-1,687	-1,776	-1,176	-374
Net Income (Loss) Attributable to Parent
-12,500	46,800	43,200	-9,500	-26,000	-3,400	20,900	50,100	-4,900	33,948	33,551	4,616	10,485	37,416	21,340	-10,947	3,991	-	36,943	-	-	-	-	-	-	15,222	13,491	10,484	-8,062	16,104	6,617	7,632	-6,829	28,657	1,549	14,210	-21,397	13,120	9,808
Earnings Per Share [Abstract]
Net income (loss) per share - basic:
Net income per share from continuing operations-basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	0.81	0.50	-0.05	0.30	-	1.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share from discontinued operations-basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	0.13	0.02	-0.22	-0.20	-	-0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in dollars per share)
-0.24	0.91	0.84	-0.18	-0.51	-0.07	0.42	1.00	-0.10	0.80	0.81	0.11	0.26	0.94	0.52	-0.27	0.10	0.89	0.94	0.37	-0.57	0.82	0.58	0.13	-0.55	0.42	0.37	0.29	-0.22	0.45	0.18	0.21	-0.19	0.82	0.04	0.40	-0.61	0.42	0.32
Net income (loss) per share - diluted:
Net income from continuing operations-diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	0.70	0.43	-0.05	0.27	-	0.90	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) per share from discontinued operations-diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	0.15	0.02	-0.22	-0.17	-	-0.11	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in dollars per share)
-0.24	0.90	0.83	-0.18	-0.51	-0.07	0.41	0.98	-0.10	0.69	0.68	0.11	0.23	0.85	0.45	-0.27	0.10	0.87	0.79	0.32	-0.57	0.81	0.49	0.13	-0.55	0.42	0.36	0.29	-0.22	0.45	0.18	0.21	-0.19	0.82	0.04	0.39	-0.61	0.41	0.31
Shares used in computing loss per share
Basic (in shares)
52,000	51,700	51,600	51,500	51,200	50,819	50,100	49,900	49,580	44,235	41,222	41,013	40,727	40,589	40,465	40,202	39,542	39,120	38,831	38,480	37,949	37,601	37,507	37,416	36,854	36,420	36,272	36,144	35,968	35,890	36,202	36,182	36,045	35,981	35,855	35,619	35,179	31,301	31,097
Diluted (in shares)
52,000	54,600	52,300	51,500	51,200	53,319	51,500	51,200	49,580	50,935	50,467	50,078	49,718	59,196	49,440	40,202	48,359	55,879	47,784	47,410	37,949	61,466	46,557	38,333	36,854	37,479	37,015	36,527	35,968	36,410	36,670	36,556	36,045	36,529	36,447	36,667	35,179	32,113	31,900
Product sales, net
Total revenues
148,200	310,800	256,200	183,500	153,000	217,300	133,300	180,100	75,800	161,625	114,296	63,610	81,969	87,516	96,698	48,333	63,753	111,143	117,512	82,023	18,291	83,352	84,457	78,269	35,767	85,670	76,297	65,596	30,359	74,350	54,011	53,161	34,357	81,670	43,663	71,479	5,597	67,266	55,872
Contract Manufacturing [Member]
Total revenues
21,700	25,400	20,000	18,700	15,900	27,100	22,100	23,600	26,100	16,200	18,912	16,160	17,628	16,645	14,712	10,156	7,587	10,525	11,341	8,859	12,243	9,598	9,433	9,187	2,726	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Contracts and grants
Total revenues
22,600	24,200	35,600	41,000	21,700	26,400	18,200	16,500	15,900	16,011	16,226	21,002	17,261	47,520	31,504	32,752	31,624	19,540	29,525	35,230	33,099	9,353	44,064	22,869	15,391	12,437	12,805	16,840	12,741	20,256	12,581	17,218	15,954	26,278	15,099	16,662	12,936	6,720	6,266